Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.19 -0.03 (-14.42%)
As of: Oct 22, 2026 · 3:47 PM EDT

Senti Biosciences Holdings (SNTI) Debt Ratio (2026)

Updated

Senti Biosciences Holdings' (SNTI) Debt Ratio came in at 0.12 for Q2 2026.

Analysis

Senti Biosciences Holdings (SNTI) Debt Ratio (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,167.71 Bn 1,136.29 Bn 19.71 Bn 0.39
2 Johnson & Johnson 647.75 Bn 567.61 Bn 17.30 Bn 0.23
3 AbbVie 503.60 Bn 476.71 Bn 12.70 Bn 0.52
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn 0.42
5 Novartis Ag 303.19 Bn 267.18 Bn 11.24 Bn 0.08
6 Astrazeneca 268.04 Bn 241.73 Bn 12.86 Bn 0.28
7 Amgen 242.69 Bn 198.09 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.89 Bn 169.09 Bn 6.22 Bn 0.53
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn 0.31
10 Senti Biosciences Holdings 5.80 Mn -50.96 Mn - 0.12
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.12
API Access

Senti Biosciences Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SNTI&period=max&api_key=YOUR_API_KEY